Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 16;5(3):126-129.
doi: 10.1089/phage.2023.0037. eCollection 2024 Sep.

Aerosolic Application of Phages Against S. infantis on Plates and Chicken Skin

Affiliations

Aerosolic Application of Phages Against S. infantis on Plates and Chicken Skin

Lisa Winkelmayer et al. Phage (New Rochelle). .

Abstract

Phages are known as a promising method to combat antimicrobial resistance (AMR) in the human and veterinary sector. Use of phage aerosols enormously increases the application field, although the impact on the infectivity of phages during nebulization needs to be evaluated. In this study S. infantis was treated on plates and chicken skin with nebulized phage particles of the Myoviridae type, identified by transmission electron microscopy, using a commercial nebulizer primarily used for H2O2 disinfection. The reduction of bacterial number by aerosol applied phage particles was evaluated. It could clearly be shown that the phage particles were able to infect Salmonella after being nebulized using ultrasound technology. Further studies on other types of phages as well as other conditions must be performed to standardize the aerosolic application of phages.

Keywords: AMR; Myoviridae; S. infantis; aerosol; nebulization.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
A. Reduction of CFU/mL (Colony Forming Units) of S. infantis colony after phage nebulization. (P) represents the LB agar plate matrix, whereas (skin) are the chicken skin samples (1 cm × 1 cm). Only bacteria colonies from 10 to 300 were counted, so threshold of maximum of 300 colonies were set. E1 – Experiment 1 displayed fully eradication of bacteria on both plates and skin samples, while the mean of E2 and E3 showed quantitative reduction by 10–3 dilution. B. Reduction of S. infantis after treatment with collected nebulized phage particles, which show a reduction of bacteria, and additionally with H2O2 nebulized phage particles, which lead to phage inactivation and growth of S. infantis.
FIG. 2.
FIG. 2.
S. infantis phage of the Myoviridae family by using transmission electron microsocopy (TEM) before nebulization for characterization.

References

    1. Żaczek M, Weber-Dąbrowska B, Międzybrodzki R, et al. Phage therapy in Poland—a Centennial journey to the first ethically approved treatment facility in Europe. Front Microbiol 2020;11:1056; doi: 10.3389/fmicb.2020.01056 - DOI - PMC - PubMed
    1. Briot T, Kolenda C, Ferry T, et al. PHAGEinLYON study group . Paving the way for phage therapy using novel drug delivery approaches. J Control Release 2022;347:414–424; doi: 10.1016/j.jconrel.2022.05.021 - DOI - PubMed
    1. Durr HA, Leipzig ND. Advancements in bacteriophage therapies and delivery for bacterial infection. Mater Adv 2023;4(5):1249–1257; doi: 10.1039/d2ma00980c - DOI - PMC - PubMed
    1. Chang RYK, Wallin M, Lin Y, et al. Phage therapy for respiratory infections. Adv Drug Deliv Rev 2018;133:76–86; doi: 10.1016/j.addr.2018.08.001 - DOI - PMC - PubMed
    1. Wang X, Xie Z, Zhao J, et al. Prospects of Inhaled Phage Therapy for combatting pulmonary infections. Front Cell Infect Microbiol 2021;11:758392; doi: 10.3389/fcimb.2021.758392 - DOI - PMC - PubMed

LinkOut - more resources